China Resources Sanjiu Pharmaceutical
China Resources Sanjiu Pharmaceutical is a large state-owned pharmaceutical listed company.
Launch date
Employees
Market cap
AUD9.9b
Enterprise valuation
AUD8.7b (Public information from Sep 2024)
Share price
CNY37.8 000999.SZ
China (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 13.6b | 15.3b | 18.1b | 24.7b | 27.6b | 31.2b | 33.8b |
| % growth | (7 %) | 12 % | 18 % | 37 % | 12 % | 13 % | 8 % |
| EBITDA | 2.7b | 3.2b | 3.7b | 4.9b | 5.0b | 5.8b | 6.4b |
| % EBITDA margin | 20 % | 21 % | 20 % | 20 % | 18 % | 18 % | 19 % |
| Profit | 1.6b | 2.0b | 2.4b | 2.9b | 3.4b | 3.8b | 4.3b |
| % profit margin | 12 % | 13 % | 14 % | 12 % | 12 % | 12 % | 13 % |
| EV / revenue | 1.5x | 2.0x | 2.4x | 1.8x | 2.0x | 1.7x | 1.5x |
| EV / EBITDA | 7.6x | 9.6x | 11.9x | 9.2x | 10.8x | 9.0x | 7.7x |
| R&D budget | 460m | 560m | 594m | 715m | - | - | - |
| R&D % of revenue | 3 % | 4 % | 3 % | 3 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
| Total Funding | - | ||
Related Content
Recent News about China Resources Sanjiu Pharmaceutical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
